120 related articles for article (PubMed ID: 27496443)
1. Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients.
Zegarska J; Hryniewiecka E; Zochowska D; Samborowska E; Jazwiec R; Borowiec A; Tszyrsznic W; Chmura A; Nazarewski S; Dadlez M; Paczek L
Transplant Proc; 2016 Jun; 48(5):1539-42. PubMed ID: 27496443
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients.
Zegarska J; Hryniewiecka E; Zochowska D; Samborowska E; Jazwiec R; Maciej K; Nazarewski S; Dadlez M; Paczek L
Transplant Proc; 2018 Sep; 50(7):2235-2239. PubMed ID: 30177142
[TBL] [Abstract][Full Text] [Related]
3. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
[TBL] [Abstract][Full Text] [Related]
4. Quantification of tacrolimus and three demethylated metabolites in human whole blood using LC-ESI-MS/MS.
Dubbelboer IR; Pohanka A; Said R; Rosenborg S; Beck O
Ther Drug Monit; 2012 Apr; 34(2):134-42. PubMed ID: 22406653
[TBL] [Abstract][Full Text] [Related]
5. Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function.
Han SS; Yang SH; Kim MC; Cho JY; Min SI; Lee JP; Kim DK; Ha J; Kim YS
PLoS One; 2016; 11(4):e0153491. PubMed ID: 27082871
[TBL] [Abstract][Full Text] [Related]
6. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
[TBL] [Abstract][Full Text] [Related]
7. Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies.
Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; Van Gelder T; Sallustio BC
Ther Drug Monit; 2013 Oct; 35(5):617-23. PubMed ID: 23921430
[TBL] [Abstract][Full Text] [Related]
8. Determination of tacrolimus in human whole blood in kidney transplant recipients using a rapid and specific LC-MS/MS method.
Hieu TB; Dung NM; Toan PQ; Kien TQ; Van Duc N; Thang LV; Van Tran P; Hop VQ; Phuong NM; Ben NH; Van Khoi N; Nghia TT; Dung VD; Van Thinh N; Hang DTT; Van Men C; Long DD; Su HX
J Clin Lab Anal; 2023 Aug; 37(15-16):e24958. PubMed ID: 37621139
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Elective Conversion From Sotrastaurin (STN) to Tacrolimus (TAC) or Mycophenolate (MPS) in Stable Kidney Transplant Recipients.
Hannun P; Felipe C; Ferreira A; Sandes-Freitas T; Cristelli M; Aguiar W; Franco M; Campos E; Gerbase de Lima M; Tedesco-Silva H; Medina-Pestana J
Ther Drug Monit; 2016 Jun; 38(3):293-9. PubMed ID: 26919549
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients.
Lemaitre F; Antignac M; Fernandez C
Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394
[TBL] [Abstract][Full Text] [Related]
11. Impact of tacrolimus on bone metabolism after kidney transplantation.
Luo L; Shi Y; Bai Y; Zou Y; Cai B; Tao Y; Lin T; Wang L
Int Immunopharmacol; 2012 May; 13(1):69-72. PubMed ID: 22469633
[TBL] [Abstract][Full Text] [Related]
12. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus.
de Sandes-Freitas TV; Felipe CR; Campos ÉF; de Lima MG; Soares MF; de Franco MF; Aguiar WF; Tedesco-Silva H; Medina-Pestana JO
Transplantation; 2015 Nov; 99(11):2372-81. PubMed ID: 25929604
[TBL] [Abstract][Full Text] [Related]
13. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
Plischke M; Riegersperger M; Dunkler D; Heinze G; Kikić Ž; Winkelmayer WC; Sunder-Plassmann G
PLoS One; 2015; 10(8):e0135674. PubMed ID: 26270340
[TBL] [Abstract][Full Text] [Related]
14. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
15. Intracellular tacrolimus concentration correlates with impaired renal function through regulation of the IS-AHR-ABC transporter in peripheral blood mononuclear cells.
Guo P; Zhang R; Zhou J; Li P; Liu Y; Shi S
Int Immunopharmacol; 2024 Jan; 126():111233. PubMed ID: 37979449
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus metabolite cross-reactivity in different tacrolimus assays.
Murthy JN; Davis DL; Yatscoff RW; Soldin SJ
Clin Biochem; 1998 Nov; 31(8):613-7. PubMed ID: 9876892
[TBL] [Abstract][Full Text] [Related]
17. Impact of a Clinical Solid Organ Transplant Pharmacist on Tacrolimus Nephrotoxicity, Therapeutic Drug Monitoring, and Institutional Revenue Generation in Adult Kidney Transplant Recipients.
Griffin SP; Nelson JE
Prog Transplant; 2016 Dec; 26(4):314-321. PubMed ID: 27628498
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts.
Shimizu T; Tanabe K; Tokumoto T; Ishikawa N; Shinmura H; Oshima T; Toma H; Yamaguchi Y
Clin Transplant; 1999; 13 Suppl 1():48-53. PubMed ID: 10751057
[TBL] [Abstract][Full Text] [Related]
19. Determination of Concentrations of Azathioprine Metabolites 6-Thioguanine and 6-Methylmercaptopurine in Whole Blood With the Use of Liquid Chromatography Combined With Mass Spectrometry.
Zochowska D; Zegarska J; Hryniewiecka E; Samborowska E; Jazwiec R; Tszyrsznic W; Borowiec A; Dadlez M; Paczek L
Transplant Proc; 2016 Jun; 48(5):1836-9. PubMed ID: 27496503
[TBL] [Abstract][Full Text] [Related]
20. Infection rates in tacrolimus versus cyclosporine-treated pediatric kidney transplant recipients on a rapid discontinuation of prednisone protocol: 1-year analysis.
Kizilbash SJ; Rheault MN; Bangdiwala A; Matas A; Chinnakotla S; Chavers BM
Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28371243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]